The Situation
- BiotechCo* is a research-based pharmaceutical company that develops and commercializes drugs in several therapeutic areas
- BiotechCo has several products on the market and about a dozen in different stages of development
- The company has significant revenue from royalties and marketed products, with breakeven profitability
- BiotechCo's drug portfolio is increasingly complex and difficult to manage
- Public pressure is being applied by investors calling for strategic moves to jolt the stock out of its current range
Our Approach
Combine strategic priorities with project and process evaluation:
Our Recommendations
Review the highest-priority opportunities for strategic fit:
The Results
Refocus resources on highest potential projects:
* Levamos a confidencialidade de nossos clientes a sério. Embora os nomes tenham sido alterados, os resultados são reais.
